LifePoint Health Inc (LPNT) Insider David M. Dill Sells 45,000 Shares
LifePoint Health Inc (NASDAQ:LPNT) insider David M. Dill sold 45,000 shares of the company’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total value of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of LifePoint Health Inc (LPNT) opened at $48.25 on Friday. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health Inc has a 1 year low of $42.50 and a 1 year high of $70.95. The stock has a market capitalization of $1,900.00, a PE ratio of 11.43, a P/E/G ratio of 1.14 and a beta of 0.67.
LifePoint Health (NASDAQ:LPNT) last released its earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.95 by ($0.15). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.60 billion. During the same quarter in the prior year, the business posted $0.94 EPS. The business’s revenue for the quarter was down .7% compared to the same quarter last year. analysts forecast that LifePoint Health Inc will post 3.64 EPS for the current fiscal year.
Large investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of LifePoint Health by 10.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after purchasing an additional 164 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of LifePoint Health during the fourth quarter worth about $134,000. Shelton Capital Management purchased a new stake in shares of LifePoint Health during the second quarter worth about $205,000. Capstone Investment Advisors Netherlands B.V. purchased a new stake in shares of LifePoint Health during the second quarter worth about $233,000. Finally, Virtu KCG Holdings LLC purchased a new stake in shares of LifePoint Health during the second quarter worth about $326,000.
A number of analysts have commented on the company. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a research report on Thursday, January 11th. Goldman Sachs Group assumed coverage on LifePoint Health in a research report on Wednesday, January 3rd. They issued a “sell” rating and a $45.00 price target for the company. ValuEngine cut LifePoint Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. William Blair restated an “outperform” rating on shares of LifePoint Health in a research report on Tuesday, November 21st. Finally, Credit Suisse Group assumed coverage on LifePoint Health in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have given a buy rating to the company. LifePoint Health has an average rating of “Hold” and a consensus target price of $59.14.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.